Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg) 2022-02-15 16:00
Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients 2022-02-11 20:40
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories 2022-02-11 10:00
Ucello Therapeutics Completes US$25 Million Series A Financing 2022-02-11 02:16
AKESO'S NGF MONOCLONAL ANTIBODY (AK115) APPROVED TO INITIATE CLINICAL TRIAL IN PAIN (INCLUDING CANCER PAIN) 2022-02-10 17:00
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients 2022-02-09 20:00
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors 2022-02-09 17:12
Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics 2022-02-08 06:00
IonOpticks enters OEM partnership with Bruker that sets a new standard for mass spectrometry-based research 2022-02-08 00:01
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
Laekna Launched the new domain name www.laekna.com 2022-02-07 12:47
Genesis MedTech Acquires JC Medical, Creates New Structural Heart Franchise 2022-02-05 08:00
Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report 2022-02-04 19:47
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine 2022-02-04 06:54
LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology 2022-02-03 22:00
New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good 2022-02-01 21:00
Exopharm and Astellas Institute for Regenerative Medicine (AIRM) Sign Master Collaborative Services Agreement 2022-01-31 19:00
AKESO'S LIGUFALIMAB AND IVONESCIMAB OBTAINED APPROVAL TO INITIATE A PHASE II TRIAL 2022-01-31 10:14
AKESO DOSES FIRST PATIENT IN THE PHASE III TRIAL OF IVONESCIMAB COMBINED WITH CHEMOTHERAPY IN EGFR-TKI RESISTANT EGFR MUTATION ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER 2022-01-31 09:51
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital 2022-01-29 11:37
1 88 89 90 91 92 222